Despite the nearly complete depletion of developing B cells during early infection, the frequencies of naïve, germinal center and memory B cells harboring viral genome in the anti-IL-7 treatment group were nearly identical to that of mock and isotype control groups (Fig. 10B). The gene discussed is IL7; the disease is infection.